A recent preprint from medRxiv identified a gene that is thought to be a risk factor for developing Long Covid, complementing another article published in Nature which also reported that the gene FOXP4 increases the risk of Long COVID by 1.6-fold. The current study pooled data from several previous COVID-19 genetics studies, including one identifying FOXP4 as increasing the risk of severe COVID.
Read More »A recent article published by Science Insider discussed a new concern about COVID-19 vaccine side effects colloquially termed “Long Vax.” There have been rare reports of people developing symptoms of small fiber neuropathy (SFN) and/or postural orthostatic tachycardia syndrome (POTS) following vaccination for COVID-19. These conditions lead to persistent headaches, fatigue, and problems with heart rate and blood pressure, similar to those developed in cases of Long Covid.
Read More »A recent paper outlined the findings of a new study on the safety and efficacy of COVID-19 vaccines in patients with Multiple Sclerosis (MS), Neuromyelitis Optica spectrum disorder (NMOSD), and Myelin Oligodendrocyte Glycoprotein antibody disease (MOGAD). Researchers in South Korea examined the medical records of 56 patients (19 with MS, 22 with NMOSD, and 15 with MOGAD) to determine the effects of vaccination on this population.
Read More »A recent review article covers current knowledge about COVID-19 vaccination in those with inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis. The authors concluded that IBD patients are not at increased risk of infection or serious illness from Covid-19. With the exception of patients taking corticosteroids, most IBD therapies have been shown not to increase the risk of covid-19.
Read More »